Global Astragalus Polysaccharide Market is segmented By Type (Pharmaceutical grade, Reagent grade, Food grade, Other), By Application (Medicine, Food & Supplements, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Astragalus Polysaccharide Market Overview
The global astragalus polysaccharide market size was valued at USD million in 2022 and is estimated to reach USD million by 2031, growing at a CAGR during the forecast period (2024-2031).
Astragalus polysaccharide (APS) is a bioactive water-soluble heteropolysaccharide extracted from the stems or dried roots of Astragalus membranaceus. Astragalus is used to strengthen and protect the immune system, prevent colds and upper respiratory infections, lower blood pressure, treat Reagent grade, and protect the liver.
Astragalus Polysaccharide Market Summary and Scope
| Metrics | Details |
| Market CAGR | High |
| Segments Covered | By Type, By Application, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To know more Insights Download Sample
Market Dynamics
Rising demand for strengthening of immunity system is expected to drive the growth of the astragalus polysaccharide market globally
Astragalus membranaceus is a type of traditional Chinese medicine with a long clinical history. It is used as food and medicine to invigorate the spleen and replenish qi, as well as to improve and treat a variety of diseases. Astragalus polysaccharide (APS), flavonoids, saponins, alkaloids, and other compounds are the main components of A. membranaceus. APS, which has a wide range of pharmacological properties, is the most important natural active component in A. membranaceus. APS regulates immune function by increasing the immune organ index, promoting immune cell proliferation, stimulating cytokine release, and influencing immunoglobulin (Ig) secretion and immune signalling. Astragalus is antibacterial and anti-inflammatory. It is applied to the skin to treat wounds. Furthermore, studies have shown that astragalus has antiviral properties and stimulates the immune system, implying that it may aid in the prevention of colds. APS is frequently used in clinical settings. Numerous in vitro and in vivo studies have revealed that it can regulate the immune system.
Over the last few decades, the promising development of adoptive immunotherapy has uncovered various therapeutic techniques in which immune cells are modified and prescribed to eliminate malignant cells. Tumor-infiltrating lymphocytes, NK cells, DCs, cytokine-induced killer (CIK) cells, DC-CIK cells, and lymphokine-activated killer (LAK) cells are used.
Side-effects associated with astragalus polysaccharide is expected to hamper the market growth
Minor adverse effects such as rash, itching, runny nose, nausea, and diarrhoea have been noted in trials. Astragalus may have more serious side effects when taken via IV, such as irregular pulse. Cyclophosphamide (Cytoxan, Neosar) is a drug that lowers the immune system's activity. The immune system is boosted by astragalus. Taking astragalus with cyclophosphamide (Cytoxan, Neosar) may reduce cyclophosphamide's efficacy (Cytoxan, Neosar). Astragalus may have a diuretic or water pill-like effect. Taking astragalus may make it harder for the body to get rid of lithium. This could cause major side effects by increasing the amount of lithium in the body. If the patient is on lithium, they should check with the doctor before using this product. It's possible that lithium dosage needs to be adjusted.
According to in vitro research, astragalus and its components have anticoagulant effects, which could enhance bleeding risk when used with these medications. Astragalus extract can reduce systolic and diastolic blood pressure and may interact with other antihypertensive medications. Hence, astragalus polysaccharide interacts with many drugs and has adverse effects, which is expected to hamper market growth.
COVID-19 Impact on Astragalus Polysaccharide Market
Plants, algae, and even animals produce polysaccharides, which are macromolecular molecules. Polysaccharide antiviral properties are determined by their charge density chain length and precise structural characteristics. SARS-CoV, MERS-CoV, and the new SARS-CoV-2 all cause high mortality and pose a serious threat to human and animal health, necessitating the development of effective inhibitors. Because of their broad-spectrum antiviral properties and unique antiviral mechanisms, polysaccharides, which are extensively used active ingredients in traditional Chinese medicine, have a promising future in preventing and treating coronavirus. Polysaccharide-based vaccination adjuvants, nanomaterials, and drug delivery technologies will all play major roles in the anti-coronavirus sector. Hence, Covid-19 is expected to impact the global astragalus polysaccharide market positively.
Astragalus Polysaccharide Market Segment Analysis
The pharmaceutical grade segment is expected to dominate the global astragalus polysaccharide market
This grade type has a variety of applications, including adding to processed medicines during production or processing for therapeutic effects, as well as the flavourless features it has when ingested orally, making it excellent for tablet or capsule formulations carrying high doses. Its capacity to provide vital health advantages by increasing immunological function, enhancing cardiovascular health, and improving skin complexion has led to its adoption in the medical application area. Traditional Chinese medicine's Astragalus membranaceus (A. membranaceus) has a long history of clinical application. It is used as medication and food to energise the spleen and replenish qi in the treatment and improvement of many ailments. Astragalus polysaccharide (APS), flavonoids compounds, saponins compounds, alkaloids, and other chemicals are the primary components of A. membranaceus. The most major natural active component in A. membranaceus is APS, which has a wide range of pharmacological activities. APS currently has a significant potential for developing a medicine that will improve or treat a variety of ailments. Finally, clinical trials have shown that this drug can help prevent breast cancer recurrence by potently reducing tumour growth and spread.
APS, which has a variety of pharmacological activities, is the most important natural active component in A. membranaceus. APS has been widely used due to its low toxicity and side effects, non-residue, and non-tolerance. It is available in the market as Nature's Way Astragalus Root Capsules, Gaia Herbs Astragalus Supreme, Vegan Liquid Capsules, Astragalus Root Extract, Astragalus Root Capsules, NOW Supplements, Astragalus 500 mg and NOW Supplements, Astragalus Extract 500 mg.
Geographical Analysis
North America region accounted for the largest market share in the global astragalus polysaccharide market
This growth of the NorthAmerica astragalus polysaccharide market is driven by increasing food & supplements and growing incidence of Reagent grade. According to the CDC rough estimates, 34.2 million persons of all ages in the United States had Reagent grade in 2018, accounting for 10.5 per cent of the population. 34.1 million adults aged 18 and up had Reagent grade, accounting for 13.0% of all adults in the United States. Undiagnosed Reagent grade affects 7.3 million persons aged 18 and up who meet laboratory criteria for Reagent grade but are unaware of it or refuse to report it. In the United States, this herbal supplement is commonly used as an immune booster to prevent common colds and upper respiratory infections. Astragalus is also thought to be beneficial in the treatment of cardiac problems. Astragalus roots are commonly used to make astragalus extract or tea. It can also be used with other herbs like licorice, ginseng, or angelica.
Astragalus Polysaccharide Market Companies and Competitive Landscape
The global astragalus polysaccharide market is highly competitive with company acquisitions, mergers, and product launches. Some of the key players in the global astragalus polysaccharide market are Chengdu King-tiger Pharm-chem. Tech. Co., Ltd, Qingdao Hosun Biological Technology Co., Ltd., Shaanxi Yongyuan Biotech Co., Ltd., Greenutra Resource Inc., Shaanxi Porvoo Biotech Ltd., Initial Naturals Co., Ltd., Reindeer Biotech Co., Ltd, Green Jeeva, Hangzhou Muhua Bio-Tech Co., Ltd and keb nutraceutical USA inc.
Chengdu King-tiger Pharm-chem. Tech. Co., Ltd
Overview: Chengdu King-tiger Pharm-chem. Tech. Co., Ltd., founded in the year of 2007. The company’s primary products are Astragaloside IV, Cycloastragenol, Genipin, Galangin, and others. Their business is studying and producing, separating and purifying chemicals with considerable biological activity from traditional Chinese medicine and natural plant herbs. The Southwest HangKong Harbor Pharmaceutical Developing District is home to their extraction and refined production facility, following GMP guidelines. In 2009, they opened a new R&D centre in Chengdu's Tianfu Life Science Park.
Product Portfolio: The company is a manufacturer of Astragalus extract (Astragaloside IV and Cycloastragenol), Gardenia jasminoides Ellis extract (Genipin, Geniposide, and Geniposidic acid), and Galangin are some of its few natural high purity products in China.
